A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP ASSESSMENT OF THE SAFETY AND EFFICACY OF TELMISARTAN 40MG PLUS HYDROCHLOROTHIAZIDE 12.5MG (MICARDIS PLUS) IN COMPARISON WITH LOSARTAN 50MG PLUS HYDROCHLOROTHIAZIDE 12.5MG IN TAIWANESE PATIENTS WITH MILD TO MODERATE HYPERTENSION: